首页> Ophthalmic Research: Journal for Research in Experimental and Clinical Ophthalmology> Does ranibizumab (Lucentis?) change retrobulbar blood flow in patients with neovascular age-related macular degeneration?

Does ranibizumab (Lucentis?) change retrobulbar blood flow in patients with neovascular age-related macular degeneration?

导出原文传递

翻译打印收藏纠错

第一作者： Mete,A.

作者： Mete,A. ^[1] ; Saygili,O. ^[2] ; Gungor,K. ; Bayram,M. ; Bekir,N.

作者单位： Department of Ophtalmology, School of Medicine, Gaziantep University, Gaziantep, Turkey ^[1] Department of Radiology, Gaziantep University, School of Medicine, TR-27310 Sahinbey, Gaziantep ^[2]

关键词 Color Doppler imaging Intravitreal ranibizumab Neovascular age-related macular degeneration Retrobulbar blood flow

发布时间 2013-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Ophthalmic Research

2012年47卷3期

141-145页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

点击下载本期目录封面

Ophthalmic Research

2012年47卷3期

141-145页

检索历史清除

Does ranibizumab (Lucentis?) change retrobulbar blood flow in patients with neovascular age-related macular degeneration?

Ophthalmic Research

相似文献

同项目论文

Ophthalmic Research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Does ranibizumab (Lucentis?) change retrobulbar blood flow in patients with neovascular age-related macular degeneration?

Ophthalmic Research

相似文献

同项目论文

Ophthalmic Research

相关期刊

检索历史清除